Avanos Gross Profit from 2010 to 2025

AVNS Stock

USD 15.92 0.13 0.81%

Avanos Medical Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit is likely to outpace its year average in 2025. Gross Profit is the profit Avanos Medical makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2012-12-31

Previous Quarter

95.6 M

Current Value

92.9 M

Quarterly Volatility

140.2 M

Yuan Drop

Covid

Check Avanos Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avanos Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 43 M, Interest Expense of 16.1 M or Selling General Administrative of 286.2 M, as well as many indicators such as Price To Sales Ratio of 1.49, Dividend Yield of 0.26 or PTB Ratio of 1.45. Avanos financial statements analysis is a perfect complement when working with Avanos Medical Valuation or Volatility modules.

Check out the analysis of Avanos Medical Correlation against competitors.

For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.

Latest Avanos Medical's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Avanos Medical over the last few years. Gross profit is a required income statement account that reflects total revenue of Avanos Medical minus its cost of goods sold. It is profit before Avanos Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Avanos Medical's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Avanos Medical's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 378.3 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Avanos Gross Profit Regression Statistics

	Arithmetic Mean	465,708,221
	Geometric Mean	454,619,520
	Coefficient Of Variation	22.65
	Mean Deviation	96,805,307
	Median	450,000,000
	Standard Deviation	105,498,385
	Sample Variance	11129.9T
	Range	275.3M
	R-Value	(0.85)
	Mean Square Error	3270.5T
	R-Squared	0.73
	Significance	0.000028
	Slope	(18,877,481)
	Total Sum of Squares	166948.6T

Avanos Gross Profit History

	2025	377.9 M
	2024	341.7 M
	2023	379.7 M
	2022	450 M
	2021	364.3 M
	2020	373.3 M
	2019	402.2 M

Other Fundumenentals of Avanos Medical

Gross Profit Margin

Avanos Medical Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Treasury Stock	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.9	-0.01	-0.18	0.78	0.83	0.94	0.95	0.75	0.17	0.19	0.8	0.03	0.22	0.54	0.87	0.88	0.23	0.35	0.03	-0.07	0.08	0.05	0.1
Total Stockholder Equity	0.9		0.08	-0.06	0.5	0.64	0.81	0.91	0.42	0.05	-0.09	0.64	-0.16	-0.04	0.65	0.85	0.83	-0.12	0.01	-0.16	0.17	-0.18	-0.17	-0.13
Net Tangible Assets	-0.01	0.08		-0.55	-0.1	-0.47	0.03	-0.22	-0.09	0.15	-0.41	0.28	-0.68	-0.41	0.48	0.36	-0.33	-0.34	-0.3	-0.85	0.54	-0.7	-0.78	-0.15
Retained Earnings	-0.18	-0.06	-0.55		-0.27	0.06	-0.36	0.02	-0.4	-0.76	-0.49	-0.41	0.53	-0.48	-0.47	-0.53	-0.05	-0.33	-0.35	0.52	-0.41	0.49	0.52	0.19
Accounts Payable	0.78	0.5	-0.1	-0.27		0.83	0.79	0.67	0.9	0.2	0.49	0.82	0.35	0.49	0.17	0.6	0.64	0.6	0.54	0.3	-0.3	0.33	0.36	0.13
Long Term Debt	0.83	0.64	-0.47	0.06	0.83		0.79	0.84	0.78	0.06	0.44	0.67	0.49	0.46	0.1	0.51	0.84	0.56	0.53	0.56	-0.42	0.53	0.56	0.17
Net Receivables	0.94	0.81	0.03	-0.36	0.79	0.79		0.86	0.84	0.32	0.31	0.84	-0.03	0.33	0.54	0.89	0.82	0.31	0.52	0.0	0.08	-0.03	-0.02	-0.11
Good Will	0.95	0.91	-0.22	0.02	0.67	0.84	0.86		0.62	0.03	0.15	0.61	0.11	0.19	0.44	0.77	0.96	0.1	0.28	0.12	-0.13	0.13	0.12	0.09
Total Liab	0.75	0.42	-0.09	-0.4	0.9	0.78	0.84	0.62		0.42	0.55	0.81	0.18	0.55	0.26	0.64	0.59	0.66	0.81	0.24	-0.17	0.25	0.25	0.09
Deferred Long Term Liab	0.17	0.05	0.15	-0.76	0.2	0.06	0.32	0.03	0.42		0.57	0.31	-0.48	0.56	0.56	0.43	0.09	0.43	0.48	-0.22	0.47	-0.3	-0.29	-0.22
Short Long Term Debt	0.19	-0.09	-0.41	-0.49	0.49	0.44	0.31	0.15	0.55	0.57		0.18	0.3	1.0	-0.11	0.14	0.36	0.8	0.64	0.38	-0.26	0.35	0.37	0.13
Total Current Assets	0.8	0.64	0.28	-0.41	0.82	0.67	0.84	0.61	0.81	0.31	0.18		-0.02	0.18	0.48	0.77	0.5	0.44	0.42	-0.01	0.07	-0.01	0.03	-0.09
Treasury Stock	0.03	-0.16	-0.68	0.53	0.35	0.49	-0.03	0.11	0.18	-0.48	0.3	-0.02		0.29	-0.68	-0.39	0.17	0.47	0.17	0.87	-0.79	0.89	0.91	0.42
Short Term Debt	0.22	-0.04	-0.41	-0.48	0.49	0.46	0.33	0.19	0.55	0.56	1.0	0.18	0.29		-0.09	0.17	0.4	0.78	0.62	0.38	-0.27	0.35	0.37	0.14
Intangible Assets	0.54	0.65	0.48	-0.47	0.17	0.1	0.54	0.44	0.26	0.56	-0.11	0.48	-0.68	-0.09		0.8	0.36	-0.24	-0.03	-0.62	0.66	-0.61	-0.66	-0.25
Common Stock	0.87	0.85	0.36	-0.53	0.6	0.51	0.89	0.77	0.64	0.43	0.14	0.77	-0.39	0.17	0.8		0.71	0.05	0.26	-0.41	0.37	-0.39	-0.4	-0.18
Property Plant Equipment	0.88	0.83	-0.33	-0.05	0.64	0.84	0.82	0.96	0.59	0.09	0.36	0.5	0.17	0.4	0.36	0.71		0.19	0.31	0.18	-0.17	0.17	0.17	0.09
Current Deferred Revenue	0.23	-0.12	-0.34	-0.33	0.6	0.56	0.31	0.1	0.66	0.43	0.8	0.44	0.47	0.78	-0.24	0.05	0.19		0.72	0.61	-0.42	0.59	0.62	0.23
Net Debt	0.35	0.01	-0.3	-0.35	0.54	0.53	0.52	0.28	0.81	0.48	0.64	0.42	0.17	0.62	-0.03	0.26	0.31	0.72		0.36	-0.17	0.3	0.32	0.05
Long Term Debt Total	0.03	-0.16	-0.85	0.52	0.3	0.56	0.0	0.12	0.24	-0.22	0.38	-0.01	0.87	0.38	-0.62	-0.41	0.18	0.61	0.36		-0.71	0.91	0.98	0.29
Capital Surpluse	-0.07	0.17	0.54	-0.41	-0.3	-0.42	0.08	-0.13	-0.17	0.47	-0.26	0.07	-0.79	-0.27	0.66	0.37	-0.17	-0.42	-0.17	-0.71		-0.88	-0.79	-0.7
Net Invested Capital	0.08	-0.18	-0.7	0.49	0.33	0.53	-0.03	0.13	0.25	-0.3	0.35	-0.01	0.89	0.35	-0.61	-0.39	0.17	0.59	0.3	0.91	-0.88		0.95	0.64
Net Working Capital	0.05	-0.17	-0.78	0.52	0.36	0.56	-0.02	0.12	0.25	-0.29	0.37	0.03	0.91	0.37	-0.66	-0.4	0.17	0.62	0.32	0.98	-0.79	0.95		0.39
Capital Stock	0.1	-0.13	-0.15	0.19	0.13	0.17	-0.11	0.09	0.09	-0.22	0.13	-0.09	0.42	0.14	-0.25	-0.18	0.09	0.23	0.05	0.29	-0.7	0.64	0.39

Click cells to compare fundamentals

About Avanos Medical Financial Statements

Avanos Medical shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although Avanos Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Avanos Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Avanos Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Gross Profit	341.7 M	377.9 M
Gross Profit Margin	0.51	0.37

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Avanos Stock Analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC